Grace Announces Additional Patent Notices of Allowance for Flash Chromatography Technology
News Feb 11, 2013
W. R. Grace & Co. has announced that the U.S. Patent and Trademark Office has granted three additional Notices of Allowance related to the company’s Reveleris® flash chromatography system.
The benefits derived from these allowed claims enable streamlined purification of new chemical/biological entities for drug discovery.
These notices describe actively controlling the split flow, using chromaphoric solvents, and collecting fractions based on a wavelength range during flash chromatography.
These techniques streamline purification of new chemical/biological entities during drug discovery by increasing recovery, improving reliability and simplifying instrument operation.
Grace previously announced receipt of a patent for the use of Evaporative Light Scattering Detection (ELSD) with flash chromatography, a key part of the Reveleris® flash chromatography system.
“These additional U.S. Patent Allowances further confirm our leadership in flash chromatography technology,” said Laurie Andriate, Vice-President/General Manager of Discovery Sciences, a product line of Grace Materials Technologies.
Andriate continued, “Our cutting-edge technology has advanced the capabilities of flash chromatography, resulting in cost savings and productivity enhancements for our customers.”
The award winning Reveleris® flash chromatography system and Grace’s innovative silica cartridges are used by most leading pharmaceutical companies in the world.
Grace has combined its expertise as the world’s largest manufacturer of specialty silica gel with its pioneering ELSD know-how to optimize flash purification for a broad range of applications.
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE